(Q44956373)

7 December 2017

title

Factors associated with efavirenz discontinuation in a large community-based sample of patients (English)

1 reference

7 December 2017

0 references

1 reference

1

B Spire

1 reference

7 December 2017

P Carrieri

2

1 reference

7 December 2017

M-A Garzot

3

1 reference

7 December 2017

M L'henaff

4

1 reference

7 December 2017

Y Obadia

5

1 reference

7 December 2017

TRT-5 Group

6

1 reference

7 December 2017

publication date

1 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

16

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

558-564

1 reference

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

Gender differences in perceived health-related quality of life among patients with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

Detecting alcoholism. The CAGE questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

Factors associated with antiretroviral adherence among HIV-infected women with children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

Perception of quality of life by patients, partners and treating physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120410001716342

10.1080/09540120410001716342

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference